Equine herpesvirus type 1 modified live virus vaccines: quo vaditis? (Q36383825)

13 August 2017

1 reference

title

Equine herpesvirus type 1 modified live virus vaccines: quo vaditis? (English)

1 reference

Laura Brunengraber Goodman

13 August 2017

object named as

Laura B Goodman

series ordinal

2

0 references

Nikolaus Osterrieder

series ordinal

4

object named as

Nikolaus Osterrieder

1 reference

13 August 2017

Cristina T Rosas

1

1 reference

PubMed ID

16451114

13 August 2017

Jens von Einem

series ordinal

3

1 reference

13 August 2017

1 February 2006

1 reference

Expert Review of Vaccines

13 August 2017

1 reference

13 August 2017

5

1 reference

13 August 2017

1

1 reference

13 August 2017

119-131

1 reference

Epidemiological studies of equine herpesvirus 1 (EHV-1) in Thoroughbred foals: a review of studies conducted in the Hunter Valley of New South Wales between 1995 and 1997.

13 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Equid herpesvirus-induced immunosuppression is associated with lymphoid cells and not soluble circulating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

In vitro characterisation of high and low virulence isolates of equine herpesvirus-1 and -4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The nucleic acid content of equine abortion virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Equine viral vaccines: the past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Deleting two amino acids in glycoprotein gI of pseudorabies virus decreases virulence and neurotropism for pigs, but does not affect immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The equine herpesvirus 1 IR6 protein is nonessential for virus growth in vitro and modified by serial virus passage in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Rapid identification and differentiation of the vaccine strain Rac H from EHV 1 field isolates using a non-radioactive DNA probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Kinetics of cellular and viral DNA synthesis in equine abortion (herpes) virus infection of L-M cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Open reading frames encoding a protein kinase, homolog of glycoprotein gX of pseudorabies virus, and a novel glycoprotein map within the unique short segment of equine herpesvirus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Transcriptional analyses of the unique short segment of EHV-1 strain Kentucky A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The equine herpesvirus type 1 (EHV-1) homolog of herpes simplex virus type 1 US9 and the nature of a major deletion within the unique short segment of the EHV-1 KyA strain genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The DNA sequence of equine herpesvirus-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Sequence and organization of the genomic termini of equine herpesvirus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Sequence analysis of a glycoprotein D gene homolog within the unique short segment of the EHV-1 genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The truncated form of glycoprotein gp2 of equine herpesvirus 1 (EHV-1) vaccine strain KyA is not functionally equivalent to full-length gp2 encoded by EHV-1 wild-type strain RacL11

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Expression of the full-length form of gp2 of equine herpesvirus 1 (EHV-1) completely restores respiratory virulence to the attenuated EHV-1 strain KyA in CBA mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Contribution of gene products encoded within the unique short segment of equine herpesvirus 1 to virulence in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The open reading frames 1, 2, 71, and 75 are nonessential for the replication of equine herpesvirus type 1 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

An improved cosmid vector for the cloning of equine herpesvirus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Deletion of gene 52 encoding glycoprotein M of equine herpesvirus type 1 strain RacH results in increased immunogenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

The gene 10 (UL49.5) product of equine herpesvirus 1 is necessary and sufficient for functional processing of glycoprotein M.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Oral vaccination of dogs with recombinant rabies virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Gene therapy progress and prospects: viral trafficking during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Potential of equine herpesvirus 1 as a vector for immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.5.1.119

21 January 2018

Identifiers

DOI

10.1586/14760584.5.1.119

1 reference

13 August 2017

1 reference

PubMed ID

16451114